Selenium (Selenocysteine).

Selenocysteine is the catalytic residue at the active site of glutathione peroxidase, and glutathione is the reductant that resets it each cycle. The enzyme and its substrate move together.

Cysteine availability sets the rate of glutathione synthesis, and glutathione is what the selenocysteine-containing peroxidases consume. NAC keeps the reducing pool stocked.

Selenocysteine is built on a serine-charged tRNA by dedicated machinery, yet it draws on the same sulfur-amino-acid pools as cysteine and can substitute for cysteine in protein at high intakes. The two amino acids are chemically parallel.

Selenocysteine is synthesised on its tRNA from a serine backbone that receives selenium from selenophosphate. Serine is the carbon skeleton of the molecule.

Vitamin E interrupts lipid peroxidation chains and the selenocysteine-bearing peroxidases reduce the hydroperoxides already made. Each reduces demand on the other.

The three deiodinases are selenocysteine-containing enzymes that remove iodine from thyroid hormone to activate or deactivate it. Both elements are needed for normal conversion.

Thioredoxin reductase carries a selenocysteine at its C-terminus and reduces coenzyme Q10 to ubiquinol. That is a direct enzymatic link between the two.

Selenocysteine-containing thioredoxin reductase is one of the main routes that reduces lipoic acid to its dithiol form. Selenium adequacy governs lipoate recycling.

Zinc sits in copper-zinc superoxide dismutase, which converts superoxide to hydrogen peroxide, and the selenium peroxidases then remove that peroxide. The two enzymes act one after the other.

Nrf2 activation by sulforaphane raises transcription of the selenoprotein genes for glutathione peroxidase and thioredoxin reductase. Selenium supplies the element those new enzymes need.

Any selenium form contributes to one elemental total, and the usable range is narrow. Forms are summed for intake, then distinguished for their handling.

Glutathione reductase and thioredoxin reductase are both FAD-dependent flavoenzymes, and thioredoxin reductase is itself a selenocysteine enzyme. Riboflavin supplies the FAD that lets them recycle oxidised glutathione and thioredoxin back to the reduced state. Without adequate riboflavin the selenoenzyme cycle stalls at the regeneration step rather than at the selenium step.

Both reductase systems that keep selenoenzymes turning over draw reducing equivalents from NADPH. Niacin is the precursor for the NAD and NADP pool that supplies them. The relationship is a settled cofactor dependency and does not require a combination trial.

Dietary selenocysteine is not slotted straight into selenoproteins. Selenocysteine lyase, a pyridoxal-5-phosphate enzyme, cleaves it to release selenide, which is then re-activated as selenophosphate for de novo selenoprotein synthesis. The same vitamin B6 cofactor drives cystathionine beta-synthase and cystathionine gamma-lyase, which supply the cysteine that glutathione synthesis needs.

Glutathione is a tripeptide of glutamate, cysteine and glycine, and it is the substrate that glutathione peroxidases consume. Selenium supplies the enzyme, glycine supplies part of the substrate. Neither compensates for a shortfall in the other.

Glutamine is deamidated to glutamate, the first residue in glutathione. Adequate glutathione is what selenium-dependent glutathione peroxidases work on. The link is substrate supply, one step further back than glycine or cysteine.

Ascorbic acid reduces selenite to elemental selenium, which is poorly absorbed and precipitates out of solution. High-dose vitamin C taken at the same time as an inorganic selenite product can therefore lower selenium uptake. Organic forms such as selenocysteine and selenomethionine are not reduced this way, so the caution is form-specific rather than a general selenium and vitamin C conflict.

Copper and selenium appear together frequently in trace element studies, and the co-occurrence is flagged antagonistic. Both interact with sulfhydryl-rich binding proteins in the gut and liver, and high intakes of one have been associated with altered status of the other. This is association at the status-marker level, not a demonstrated cause in people at supplement doses.

Iron drives Fenton chemistry that generates hydroxyl radicals from hydrogen peroxide, while selenium-dependent glutathione peroxidases remove that same peroxide before it reacts. The two therefore sit on opposite ends of one reaction. The relationship is mechanistic and is not a reason to separate the doses.

Selenomethionine is handled by the methionine machinery and is incorporated non-specifically into body protein in place of methionine. Methionine intake therefore influences how much selenium ends up parked in general protein rather than routed into selenoenzymes. Selenocysteine bypasses this, because it is cleaved by selenocysteine lyase before the selenium is reused.

Selenate is a structural analogue of sulfate and molybdate and shares anion transporters in the gut and kidney. Very high intakes of one anion can influence handling of another. The relationship is documented for the inorganic salts and is not established for selenocysteine.